Neuphoria Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 875.33 K | $3.56 M | 0.01% | 19.30% |
| ADVISORSHARES INVESTMENTS LLC | 04/28/2026 | 155.37 K | $632.34 K | 15.78% | 3.43% |
| SHAY CAPITAL LLC | 05/15/2026 | 151.01 K | $614.61 K | -10.68% | 3.33% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 142.18 K | $578.69 K | 100.00% | 3.13% |
| 05/15/2026 | 98.52 K | $400.96 K | 100.00% | 2.17% | |
| 05/15/2026 | 76.73 K | $312.28 K | 100.00% | 1.69% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 52.01 K | $211.67 K | 200.57% | 1.15% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 47.44 K | $193.09 K | 0.00% | 1.05% |
| VANGUARD FIDUCIARY TRUST CO | 05/15/2026 | 33.59 K | $136.71 K | 100.00% | 0.74% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 30.00 K | $122.10 K | 0.00% | 0.66% |
| FNY INVESTMENT ADVISERS, LLC | 04/15/2026 | 26.50 K | $107.00 K | 0.00% | 0.58% |
| CITADEL ADVISORS LLC | 05/15/2026 | 19.33 K | $78.68 K | 100.00% | 0.43% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 14.00 K | $56.98 K | 0.00% | 0.31% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 12.03 K | $49.00 K | 100.00% | 0.27% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 11.22 K | $45.67 K | 0.13% | 0.25% |
| MERCK & CO., INC. | 05/13/2026 | 10.03 K | $40.81 K | 0.00% | 0.22% |
| UBS GROUP AG | 05/05/2026 | 2.32 K | $9.43 K | 40.19% | 0.05% |
| RHUMBLINE ADVISERS | 05/12/2026 | 202 | $822 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 58 | $236 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| DIADEMA PARTNERS LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| PERSISTENT ASSET PARTNERS LTD | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neuphoria Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Neuphoria Therapeutics Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 875,328
AdvisorShares Investments LLC: 155,367
Shay Capital LLC: 151,010
BALYASNY ASSET MANAGEMENT L.P.: 142,183
GEODE CAPITAL MANAGEMENT, LLC: 52,007
Ikarian Capital, LLC: 47,443
38.75% of Neuphoria Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.60 M shares in the last 24 months. This purchase volume represents approximately $7.28 M in transactions.